Advocates from AIDS Healthcare Foundation (AHF) recently criticized Gilead Sciences and its CEO John Martin on the news that effective Jan. 1, 2013 the company raised the price of eight drugs, including four key AIDS medications, which Gilead hiked an average of 6 percent